title: Off-label prescribing explained.  Why your doctor may recommend meds that aren't FDA-approved for your condition.
mesh_terms: D000588:Amines / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D002985:Clinical Protocols; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D017277:Drug Approval; D004348:Drug Labeling; D000077206:Gabapentin; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D056687:Off-Label Use / Q000706:statistics & numerical data*; D010146:Pain / Q000188:drug therapy; D010818:Practice Patterns, Physicians'; D055553:Prescription Drugs / Q000627:therapeutic use*; D012148:Restless Legs Syndrome / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
chemical_list: D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D055553:Prescription Drugs; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin